Vanda Pharmaceuticals to Announce Fourth Quarter 2013 Financial Results on February 13, 2014 - KFVS12 News & Weather Cape Girardeau, Carbondale, Poplar Bluff

Vanda Pharmaceuticals to Announce Fourth Quarter 2013 Financial Results on February 13, 2014

  • SPONSORED BY SOUTHEAST HEALTHMore>>

  • BJC changes charity care standards

    BJC changes charity care standards

    Sunday, April 20 2014 1:01 PM EDT2014-04-20 17:01:10 GMT
    Charity care has long been a core mission of BJC HealthCare, but the St. Louis area's largest employer is cutting back amid increasing financial pressures.
    Charity care has long been a core mission of BJC HealthCare, but the St. Louis area's largest employer is cutting back amid increasing financial pressures.
  • Clock ticking for states to adopt health exchanges

    Clock ticking for states to adopt health exchanges

    Friday, April 18 2014 2:39 PM EDT2014-04-18 18:39:20 GMT
    More than 30 states that defaulted to the federal government to run their health insurance markets under President Barack Obama's health care law must decide if they want to take a crack at it themselves. Time...
    More than 30 states that defaulted to the federal government to run their health insurance markets under President Barack Obama's health care law must decide if they want to take a crack at it themselves. Time is...
  • Blood test aims to predict breast cancer's return

    Blood test aims to predict breast cancer's return

    A new blood test may one day help predict the recurrence of breast cancer and also a woman's response to breast cancer treatment, researchers report.
    A new blood test may one day help predict the recurrence of breast cancer and also a woman's response to breast cancer treatment, researchers report.

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Vanda Pharmaceuticals Inc.

Conference Call and Webcast to Follow

WASHINGTON, Jan. 23, 2014 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced it will release results for the fourth quarter of 2013 on Thursday, February 13, 2014, before the market opens.

The Company will host a conference call at 10:00 AM ET on Thursday, February 13, 2014, during which Vanda management will discuss the fourth quarter and full year 2013 financial results and other corporate activities. To participate in the conference call, please dial 1-888-895-5271 (domestic) or 1-847-619-6547 (international) and use passcode 36518617.

The conference call will be broadcast simultaneously and archived on the Company's website, www.vandapharma.com.  Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Thursday, February 13, 2014, beginning at 12:30 PM ET and will be accessible until Thursday, February 20, 2014, at 11:59 PM ET.  The replay call-in number is 1-888-843-7419 for domestic callers and 1-630-652-3042 for international callers.  The passcode number is 36518617.

ABOUT VANDA PHARMACEUTICALS INC.:
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.  For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.  

Investor Contact:
Chad Rubin
Vice President
The Trout Group
(646) 378-2947
crubin@troutgroup.com

 


 

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

310 Broadway
Cape Girardeau, MO 63701

FCC Public File
publicfile@kfvs12.com
573-335-1212
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and KFVS12. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.